Gastroenterologist Gary Gray, part of Stanford Medicine for nearly 50 years, helped find the molecular cause of celiac disease and a potential treatment.
Hepatitis C treatment low
Antiviral medicine eliminates hepatitis C in 97% of patients, but Stanford Medicine researchers and colleagues find that many don’t receive the treatment.
Antivirals may benefit some inpatients
Elevated virus levels in hospitalized COVID-19 patients’ blood predicts worsening respiratory symptoms and suggests ongoing viral replication in later disease stages, Stanford Medicine-led study says.
Blood sugar control helps teens’ brains
Diabetes treatment technology improved teenagers’ blood sugar levels and benefited their brain structure and function, according to a study led by Stanford Medicine researchers.
Keto and Mediterranean good for diabetes
In a trial of the two low-carb diets, both were similarly effective in controlling blood glucose. Keto’s more severe carb restrictions did not provide additional overall health benefits.
Possible treatment for mucus-induced lung diseases
Stanford Medicine investigators and their collaborators have designed a compound that’s uniquely capable of blocking excessive mucus secretion — a hallmark of several serious respiratory disorders.
Ami Bhatt on gut microbiomes
The Stanford Medicine professor on why it’s important to better understand the microbiome of people transitioning from traditional to Westernized lifestyles.
COVID-19 hospitalizations among kids likely overcounted
Children being treated in hospitals are tested for SARS-CoV-2, but many who test positive never develop COVID-19 symptoms, leading to overestimates of disease severity, a study found.
Half-million COVID-19 tests at Stanford Medicine
Stanford Medicine, one of the first medical centers in the country to conduct clinical tests for COVID-19, has remained at the cutting edge of coronavirus detection.
Study of COVID-19 saliva test
An at-home COVID-19 test, designed by Stanford researchers to be easy to use and provide results within 30 minutes, will be the focus of a study funded by the Stanford Medicine Catalyst Program.
Biomarker for lipedema discovered
Researchers have identified a molecule that ties lipedema to other lymphatic diseases, such as lymphedema, and distinguishes it from obesity.
New center for rare eye disease
A $10 million gift has enabled the launch of a center focusing on optic disc drusen, a poorly understood eye disease that can lead to visual impairment or even blindness.
- Aging & Geriatrics
- AI, Technology & Innovation
- Anesthesiology & Pain Management
- Animal Research
- Autoimmune Conditions
- Blood Disorders (Hematology)
- Cellular & Molecular Biology
- Community Programs
- Data Sciences
- Diversity, Equity & Inclusion
- Drug Development
- Ear, Nose & Throat
- Emergency Medicine
- Environment & Sustainability
- Epidemiology & Population Health
- Global Health
- Health Policy
- Infectious Disease
- Internal Medicine
- Kidney Health (Nephrology)
- Lung Health
- Maternal Health
- Men's Health
- Neurology & Neurosurgery
- Obstetrics & Gynecology
- Palliative Care
- Precision Health
- Preventive Medicine
- Primary Care
- Psychiatry & Mental Health
- Stanford Medicine
- Stem Cells
- Women's Health